Invivyd, Inc.

IVVDNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$53.4M

▲ 110.5% YoY

Net Income

-$52.5M

▲ 69.1% YoY

EPS

$-0.30

▲ 79.0% YoY

Cash

$226.7M

▲ 226.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.